ProQR Therapeutics VIII B.V.
Zernikedreef 9, 2333 CK Leiden, The Netherlands
About the sponsor
Clinical research is centered on cholestatic liver disease, with attention to conditions marked by impaired bile flow and progressive hepatobiliary dysfunction. The therapeutic focus includes disease mechanisms that affect bile acid handling, liver injury, and associated metabolic disturbances.
- Hepatology
- Cholestasis
- Bile Acid Metabolism
Interest in this area reflects a commitment to therapies addressing liver-specific pathways relevant to liver disease progression and symptom burden.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
